Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serological and molecular characterisation of the most prevalent weak D variants in Croatian population. | Transfus Med | 2023 | 36453092 | PubTator, text mining | PubMed |
| Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India. | Obstet Gynecol Sci | 2023 | 36444517 | PubTator, text mining | PubMed |
| Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens. | J Infect Dis | 2023 | 36408632 | PubTator, text mining | PubMed |
| Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles. | Transfusion | 2023 | 36382965 | PubTator, text mining | PubMed |
| [Genotyping and its applications, a look to the future]. | Rev Med Inst Mex Seguro Soc | 2023 | 36378105 | PubTator, text mining | PubMed |
| Polyaromatic Hydrocarbon Specific Ring Hydroxylating Dioxygenases: Diversity, Structure, Function, and Protein Engineering. | Curr Protein Pept Sci | 2023 | 36366847 | PubTator, text mining | PubMed |
| The Development and Consequences of Red Blood Cell Alloimmunization. | Annu Rev Pathol | 2023 | 36351365 | PubTator, text mining | PubMed |
| Serologically D-negative blood donors in Thailand: molecular variants and diagnostic strategy. | Blood Transfus | 2023 | 36346882 | PubTator, text mining | PubMed |
| A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID-19 susceptibility, severity, and long COVID-19. | Transfusion | 2023 | 36271437 | PubTator, text mining | PubMed |
| Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort. | Transfus Clin Biol | 2023 | 36243305 | PubTator, text mining | PubMed |
| Intramuscular Anti-D treatment for immune thrombocytopenia: A single centre experience. | Br J Haematol | 2023 | 36198407 | PubTator, text mining | PubMed |
| Resuscitative practices and the use of low-titer group O whole blood in pediatric trauma. | J Trauma Acute Care Surg | 2023 | 36156051 | PubTator, text mining | PubMed |
| Haplotype sequence collection of ABO blood group alleles by long-read sequencing reveals putative A1-diagnostic variants. | Blood Adv | 2023 | 36129841 | PubTator, text mining | PubMed |
| Comparison of RhD Typing Results by Serology and Molecular Methods. | Lab Med | 2023 | 36124749 | PubTator, text mining | PubMed |
| A case of severe hemolytic disease of newborn due to alloimmunization in primigravida. | Transfus Clin Biol | 2023 | 35944885 | PubTator, text mining | PubMed |
| Anticancer bioactivity of zerumbone on pediatric rhabdomyosarcoma cells. | J Cancer Res Clin Oncol | 2023 | 35931788 | PubTator, text mining | PubMed |
| Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy. | Blood Transfus | 2023 | 35848630 | PubTator, text mining | PubMed |
| A novel serological RhD confirmatory test for patients with warm autoimmune hemolytic anemia with a strong positive direct antiglobulin test. | Blood Transfus | 2023 | 35848627 | PubTator, text mining | PubMed |
| From the investigation of RHD-CE hybrid genes to the recognition of RHCE variants and RHD zygosity. Expanding the analysis by QMPSF in Brazilian donors and in patients with sickle cell disease. | Blood Transfus | 2023 | 35848626 | PubTator, text mining | PubMed |
| Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma. | J Cancer Res Clin Oncol | 2023 | 35764701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=34